Clinical Trial: Single Dose of Cannabis Extract Cuts Opioid Use in Acute Pain Patients
In a placebo-controlled clinical trial published in the Journal of Cannabis Research, researchers in Israel gave 69 patients with acute nerve pain either a high-dose THC/CBD tincture, a low-dose tincture, or a placebo.
Over the next 24 hours, patients in the high-dose group used roughly half as much intravenous morphine as the placebo group, with few adverse side effects reported. The authors concluded the findings “support the potential of cannabinoids as opioid-sparing agents.”
Kentucky has been hit hard by the opioid crisis, and chronic or severe pain is a qualifying condition under the state’s medical cannabis program. Learn how to apply.
